BAKER BROS ADVISORS LLC Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BROS ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of BAKER BROS ADVISORS LLC for November 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 77,976 | 5,989,017 | 10,319,430 | 10.4 M to 10.3 M (-0.75 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 11,972 | 919,520 | 1,618,548 | 1.6 M to 1.6 M (-0.73 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 2,064 | 158,527 | 312,447 | 314.5 K to 312.4 K (-0.66 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,197 | 91,937 | 198,181 | 199.4 K to 198.2 K (-0.60 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 91 | 6,989 | 52,429 | 52.5 K to 52.4 K (-0.17 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.81 | 1,335 | 102,536 | 216,569 | 217.9 K to 216.6 K (-0.61 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 13,595 | 1,006,150 | 10,397,406 | 10.4 M to 10.4 M (-0.13 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 2,087 | 154,456 | 1,630,520 | 1.6 M to 1.6 M (-0.13 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 360 | 26,643 | 314,511 | 314.9 K to 314.5 K (-0.11 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 209 | 15,468 | 199,378 | 199.6 K to 199.4 K (-0.10 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 16 | 1,184 | 52,520 | 52.5 K to 52.5 K (-0.03 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.01 | 233 | 17,244 | 217,904 | 218.1 K to 217.9 K (-0.11 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 57,979 | 4,331,524 | 10,411,001 | 10.5 M to 10.4 M (-0.55 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 8,901 | 664,980 | 1,632,607 | 1.6 M to 1.6 M (-0.54 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 1,534 | 114,603 | 314,871 | 316.4 K to 314.9 K (-0.48 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 890 | 66,491 | 199,587 | 200.5 K to 199.6 K (-0.44 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 68 | 5,080 | 52,536 | 52.6 K to 52.5 K (-0.13 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.71 | 994 | 74,260 | 218,137 | 219.1 K to 218.1 K (-0.45 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 56,764 | 4,272,831 | 10,468,980 | 10.5 M to 10.5 M (-0.54 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 8,715 | 656,009 | 1,641,508 | 1.7 M to 1.6 M (-0.53 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 1,502 | 113,061 | 316,405 | 317.9 K to 316.4 K (-0.47 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 871 | 65,563 | 200,477 | 201.3 K to 200.5 K (-0.43 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 66 | 4,968 | 52,604 | 52.7 K to 52.6 K (-0.13 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 75.27 | 973 | 73,241 | 219,131 | 220.1 K to 219.1 K (-0.44 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 36,652 | 2,703,294 | 10,525,744 | 10.6 M to 10.5 M (-0.35 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 5,627 | 415,023 | 1,650,223 | 1.7 M to 1.7 M (-0.34 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 970 | 71,543 | 317,907 | 318.9 K to 317.9 K (-0.30 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 563 | 41,524 | 201,348 | 201.9 K to 201.3 K (-0.28 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 43 | 3,171 | 52,670 | 52.7 K to 52.7 K (-0.08 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 73.76 | 628 | 46,319 | 220,104 | 220.7 K to 220.1 K (-0.28 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 77,558 | 5,758,092 | 10,562,396 | 10.6 M to 10.6 M (-0.73 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 11,907 | 884,004 | 1,655,850 | 1.7 M to 1.7 M (-0.71 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 2,052 | 152,345 | 318,877 | 320.9 K to 318.9 K (-0.64 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,190 | 88,348 | 201,911 | 203.1 K to 201.9 K (-0.59 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 91 | 6,756 | 52,713 | 52.8 K to 52.7 K (-0.17 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.24 | 1,329 | 98,668 | 220,732 | 222.1 K to 220.7 K (-0.60 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 8,204 | 607,484 | 10,639,954 | 10.6 M to 10.6 M (-0.08 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 1,260 | 93,300 | 1,667,757 | 1.7 M to 1.7 M (-0.08 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 217 | 16,068 | 320,929 | 321.1 K to 320.9 K (-0.07 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 126 | 9,330 | 203,101 | 203.2 K to 203.1 K (-0.06 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 10 | 740 | 52,804 | 52.8 K to 52.8 K (-0.02 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.05 | 141 | 10,441 | 222,061 | 222.2 K to 222.1 K (-0.06 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 24,487 | 1,820,848 | 10,648,158 | 10.7 M to 10.6 M (-0.23 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 3,759 | 279,518 | 1,669,017 | 1.7 M to 1.7 M (-0.22 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 648 | 48,185 | 321,146 | 321.8 K to 321.1 K (-0.20 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 376 | 27,959 | 203,227 | 203.6 K to 203.2 K (-0.18 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 28 | 2,082 | 52,814 | 52.8 K to 52.8 K (-0.05 %) |
Nov 28 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 74.36 | 419 | 31,157 | 222,202 | 222.6 K to 222.2 K (-0.19 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 55,365 | 4,227,024 | 10,672,645 | 10.7 M to 10.7 M (-0.52 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 8,499 | 648,884 | 1,672,776 | 1.7 M to 1.7 M (-0.51 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 1,466 | 111,927 | 321,794 | 323.3 K to 321.8 K (-0.45 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 850 | 64,896 | 203,603 | 204.5 K to 203.6 K (-0.42 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 65 | 4,963 | 52,842 | 52.9 K to 52.8 K (-0.12 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 76.35 | 949 | 72,455 | 222,621 | 223.6 K to 222.6 K (-0.42 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 16,646 | 1,292,763 | 10,728,010 | 10.7 M to 10.7 M (-0.15 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 2,556 | 198,504 | 1,681,275 | 1.7 M to 1.7 M (-0.15 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 440 | 34,171 | 323,260 | 323.7 K to 323.3 K (-0.14 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 255 | 19,804 | 204,453 | 204.7 K to 204.5 K (-0.12 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 19 | 1,476 | 52,907 | 52.9 K to 52.9 K (-0.04 %) |
Nov 20 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 77.66 | 285 | 22,134 | 223,570 | 223.9 K to 223.6 K (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 38,330 | 3,033,110 | 10,744,656 | 10.8 M to 10.7 M (-0.36 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 5,885 | 465,689 | 1,683,831 | 1.7 M to 1.7 M (-0.35 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 1,014 | 80,239 | 323,700 | 324.7 K to 323.7 K (-0.31 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 588 | 46,529 | 204,708 | 205.3 K to 204.7 K (-0.29 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 45 | 3,561 | 52,926 | 53 K to 52.9 K (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 79.13 | 657 | 51,989 | 223,855 | 224.5 K to 223.9 K (-0.29 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 3,296 | 263,978 | 10,782,986 | 10.8 M to 10.8 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 506 | 40,526 | 1,689,716 | 1.7 M to 1.7 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 87 | 6,968 | 324,714 | 324.8 K to 324.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 51 | 4,085 | 205,296 | 205.3 K to 205.3 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 4 | 320 | 52,971 | 53 K to 53 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.09 | 56 | 4,485 | 224,512 | 224.6 K to 224.5 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 53,013 | 4,244,714 | 10,786,282 | 10.8 M to 10.8 M (-0.49 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 8,139 | 651,684 | 1,690,222 | 1.7 M to 1.7 M (-0.48 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 1,403 | 112,337 | 324,801 | 326.2 K to 324.8 K (-0.43 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 814 | 65,176 | 205,347 | 206.2 K to 205.3 K (-0.39 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 62 | 4,964 | 52,975 | 53 K to 53 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.07 | 908 | 72,703 | 224,568 | 225.5 K to 224.6 K (-0.40 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 99,280 | 7,752,428 | 10,839,295 | 10.9 M to 10.8 M (-0.91 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 15,242 | 1,190,194 | 1,698,361 | 1.7 M to 1.7 M (-0.89 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 2,628 | 205,211 | 326,204 | 328.8 K to 326.2 K (-0.80 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 1,524 | 119,004 | 206,161 | 207.7 K to 206.2 K (-0.73 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 115 | 8,980 | 53,037 | 53.2 K to 53 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 78.09 | 1,702 | 132,903 | 225,476 | 227.2 K to 225.5 K (-0.75 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 15,014 | 1,220,038 | 10,938,575 | 11 M to 10.9 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 2,305 | 187,304 | 1,713,603 | 1.7 M to 1.7 M (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 397 | 32,260 | 328,832 | 329.2 K to 328.8 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 230 | 18,690 | 207,685 | 207.9 K to 207.7 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 18 | 1,463 | 53,152 | 53.2 K to 53.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.26 | 257 | 20,884 | 227,178 | 227.4 K to 227.2 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 46,511 | 3,774,912 | 10,953,589 | 11 M to 11 M (-0.42 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 7,140 | 579,495 | 1,715,908 | 1.7 M to 1.7 M (-0.41 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 1,231 | 99,910 | 329,229 | 330.5 K to 329.2 K (-0.37 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 714 | 57,949 | 207,915 | 208.6 K to 207.9 K (-0.34 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 54 | 4,383 | 53,170 | 53.2 K to 53.2 K (-0.10 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 81.16 | 796 | 64,605 | 227,435 | 228.2 K to 227.4 K (-0.35 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 7,533 | 606,473 | 11,000,100 | 11 M to 11 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 1,156 | 93,068 | 1,723,048 | 1.7 M to 1.7 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 199 | 16,021 | 330,460 | 330.7 K to 330.5 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 116 | 9,339 | 208,629 | 208.7 K to 208.6 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 9 | 725 | 53,224 | 53.2 K to 53.2 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.51 | 129 | 10,386 | 228,231 | 228.4 K to 228.2 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 11,877 | 954,711 | 11,007,633 | 11 M to 11 M (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 1,824 | 146,619 | 1,724,204 | 1.7 M to 1.7 M (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 314 | 25,240 | 330,659 | 331 K to 330.7 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 182 | 14,630 | 208,745 | 208.9 K to 208.7 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 14 | 1,125 | 53,233 | 53.2 K to 53.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 80.38 | 204 | 16,398 | 228,360 | 228.6 K to 228.4 K (-0.09 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 19,367 | 1,648,296 | 11,019,510 | 11 M to 11 M (-0.18 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 2,973 | 253,028 | 1,726,028 | 1.7 M to 1.7 M (-0.17 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 513 | 43,661 | 330,973 | 331.5 K to 331 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 297 | 25,277 | 208,927 | 209.2 K to 208.9 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 23 | 1,957 | 53,247 | 53.3 K to 53.2 K (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.11 | 332 | 28,256 | 228,564 | 228.9 K to 228.6 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 112,010 | 9,191,025 | 11,038,877 | 11.2 M to 11 M (-1.00 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 17,198 | 1,411,189 | 1,729,001 | 1.7 M to 1.7 M (-0.98 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 2,964 | 243,212 | 331,486 | 334.5 K to 331.5 K (-0.89 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 1,720 | 141,135 | 209,224 | 210.9 K to 209.2 K (-0.82 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 129 | 10,585 | 53,270 | 53.4 K to 53.3 K (-0.24 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.06 | 1,919 | 157,464 | 228,896 | 230.8 K to 228.9 K (-0.83 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 8,157 | 673,321 | 11,150,887 | 11.2 M to 11.2 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 1,252 | 103,347 | 1,746,199 | 1.7 M to 1.7 M (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 216 | 17,830 | 334,450 | 334.7 K to 334.5 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 125 | 10,318 | 210,944 | 211.1 K to 210.9 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 9 | 743 | 53,399 | 53.4 K to 53.4 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.55 | 140 | 11,556 | 230,815 | 231 K to 230.8 K (-0.06 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 4,120 | 345,678 | 11,159,044 | 11.2 M to 11.2 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 633 | 53,110 | 1,747,451 | 1.7 M to 1.7 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 109 | 9,145 | 334,666 | 334.8 K to 334.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 63 | 5,286 | 211,069 | 211.1 K to 211.1 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 5 | 420 | 53,408 | 53.4 K to 53.4 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.90 | 71 | 5,957 | 230,955 | 231 K to 231 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 62,929 | 5,235,598 | 11,163,164 | 11.2 M to 11.2 M (-0.56 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 9,661 | 803,781 | 1,748,084 | 1.8 M to 1.7 M (-0.55 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 1,665 | 138,526 | 334,775 | 336.4 K to 334.8 K (-0.49 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 966 | 80,370 | 211,132 | 212.1 K to 211.1 K (-0.46 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 74 | 6,157 | 53,413 | 53.5 K to 53.4 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.20 | 1,078 | 89,688 | 231,026 | 232.1 K to 231 K (-0.46 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 17,602 | 1,511,565 | 11,226,093 | 11.2 M to 11.2 M (-0.16 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 2,702 | 232,033 | 1,757,745 | 1.8 M to 1.8 M (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 466 | 40,018 | 336,440 | 336.9 K to 336.4 K (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 270 | 23,186 | 212,098 | 212.4 K to 212.1 K (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 21 | 1,803 | 53,487 | 53.5 K to 53.5 K (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.87 | 302 | 25,934 | 232,104 | 232.4 K to 232.1 K (-0.13 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 4,120 | 337,840 | 11,243,695 | 11.2 M to 11.2 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 633 | 51,906 | 1,760,447 | 1.8 M to 1.8 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 109 | 8,938 | 336,906 | 337 K to 336.9 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 63 | 5,166 | 212,368 | 212.4 K to 212.4 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 5 | 410 | 53,508 | 53.5 K to 53.5 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 82.00 | 71 | 5,822 | 232,406 | 232.5 K to 232.4 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 1,565 | 131,227 | 11,247,815 | 11.2 M to 11.2 M (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 240 | 20,124 | 1,761,080 | 1.8 M to 1.8 M (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 42 | 3,522 | 337,015 | 337.1 K to 337 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 24 | 2,012 | 212,431 | 212.5 K to 212.4 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 2 | 168 | 53,513 | 53.5 K to 53.5 K (0.00 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.85 | 27 | 2,264 | 232,477 | 232.5 K to 232.5 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 9,301 | 789,121 | 11,249,380 | 11.3 M to 11.2 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 1,428 | 121,155 | 1,761,320 | 1.8 M to 1.8 M (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 246 | 20,871 | 337,057 | 337.3 K to 337.1 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 143 | 12,132 | 212,455 | 212.6 K to 212.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 11 | 933 | 53,515 | 53.5 K to 53.5 K (-0.02 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 84.84 | 159 | 13,490 | 232,504 | 232.7 K to 232.5 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 21,423 | 1,913,901 | 11,258,681 | 11.3 M to 11.3 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 3,289 | 293,835 | 1,762,748 | 1.8 M to 1.8 M (-0.19 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 567 | 50,655 | 337,303 | 337.9 K to 337.3 K (-0.17 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 329 | 29,392 | 212,598 | 212.9 K to 212.6 K (-0.15 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 25 | 2,233 | 53,526 | 53.6 K to 53.5 K (-0.05 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 89.34 | 367 | 32,787 | 232,663 | 233 K to 232.7 K (-0.16 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 30,555 | 2,601,670 | 11,280,104 | 11.3 M to 11.3 M (-0.27 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 4,692 | 399,510 | 1,766,037 | 1.8 M to 1.8 M (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 809 | 68,884 | 337,870 | 338.7 K to 337.9 K (-0.24 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 470 | 40,019 | 212,927 | 213.4 K to 212.9 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 37 | 3,150 | 53,551 | 53.6 K to 53.6 K (-0.07 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.15 | 522 | 44,447 | 233,030 | 233.6 K to 233 K (-0.22 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 36,174 | 3,102,970 | 11,310,659 | 11.3 M to 11.3 M (-0.32 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 5,554 | 476,417 | 1,770,729 | 1.8 M to 1.8 M (-0.31 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 957 | 82,091 | 338,679 | 339.6 K to 338.7 K (-0.28 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 555 | 47,607 | 213,397 | 214 K to 213.4 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 42 | 3,603 | 53,588 | 53.6 K to 53.6 K (-0.08 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 85.78 | 620 | 53,183 | 233,552 | 234.2 K to 233.6 K (-0.26 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 3,663 | 319,780 | 11,346,833 | 11.4 M to 11.3 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 562 | 49,063 | 1,776,283 | 1.8 M to 1.8 M (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 97 | 8,468 | 339,636 | 339.7 K to 339.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 56 | 4,889 | 213,952 | 214 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 4 | 349 | 53,630 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 87.30 | 63 | 5,500 | 234,172 | 234.2 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 4,306 | 380,544 | 11,350,496 | 11.4 M to 11.4 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 661 | 58,416 | 1,776,845 | 1.8 M to 1.8 M (-0.04 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 114 | 10,075 | 339,733 | 339.8 K to 339.7 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 66 | 5,833 | 214,008 | 214.1 K to 214 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 5 | 442 | 53,634 | 53.6 K to 53.6 K (-0.01 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 88.38 | 74 | 6,540 | 234,235 | 234.3 K to 234.2 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 15,798 | 1,326,160 | 11,354,802 | 11.4 M to 11.4 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 2,425 | 203,566 | 1,777,506 | 1.8 M to 1.8 M (-0.14 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 418 | 35,089 | 339,847 | 340.3 K to 339.8 K (-0.12 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 242 | 20,315 | 214,074 | 214.3 K to 214.1 K (-0.11 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 18 | 1,511 | 53,639 | 53.7 K to 53.6 K (-0.03 %) |
Nov 13 2018 | GHDX | GENOMIC HEALTH INC | BAKER BROS. ADVISORS LP | Director | Sell | S | 83.94 | 271 | 22,749 | 234,309 | 234.6 K to 234.3 K (-0.12 %) |